Women with Recurrent Ovarian Cancer Should Be Screened for Various Biomarkers – Curetoday.com
|
Women with Recurrent Ovarian Cancer Should Be Screened for Various Biomarkers
Curetoday.com “MSI status in a tumor has really been something that has been a recent focus within the immunotherapy world since pembrolizumab was approved,” Jacqueline Feinberg, M.D., third-year resident at Yale New Haven Hospital and School of Medicine, said in an … |
